CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 25 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,000 | -50.0% | 1,040 | -33.9% | 0.00% | – |
| Q4 2018 | $4,000 | +300.0% | 1,573 | +57.3% | 0.00% | – |
| Q3 2018 | $1,000 | -95.7% | 1,000 | -73.7% | 0.00% | – |
| Q2 2018 | $23,000 | +4.5% | 3,808 | +14.8% | 0.00% | – |
| Q1 2018 | $22,000 | +15.8% | 3,316 | +29.2% | 0.00% | – |
| Q4 2017 | $19,000 | +11.8% | 2,567 | +8.9% | 0.00% | – |
| Q3 2017 | $17,000 | +112.5% | 2,357 | +98.7% | 0.00% | – |
| Q2 2017 | $8,000 | +100.0% | 1,186 | +103.4% | 0.00% | – |
| Q1 2017 | $4,000 | +33.3% | 583 | +16.8% | 0.00% | – |
| Q4 2016 | $3,000 | +50.0% | 499 | +54.0% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 324 | +27.6% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 254 | 0.0% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 254 | +103.2% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 125 | -49.0% | 0.00% | – |
| Q3 2015 | $1,000 | -50.0% | 245 | +5.2% | 0.00% | – |
| Q2 2015 | $2,000 | – | 233 | +0.9% | 0.00% | – |
| Q1 2015 | $0 | – | 231 | +20.9% | 0.00% | – |
| Q4 2014 | $0 | – | 191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,218,401 | $6,957,000 | 4.07% |
| BARD ASSOCIATES INC | 395,575 | $2,260,000 | 0.21% |
| Ariel Investments | 1,290,317 | $7,368,000 | 0.08% |
| Ballew Advisors, Inc | 5,557 | $31,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 205,400 | $1,173,000 | 0.01% |
| DELTA ASSET MANAGEMENT LLC/TN | 12,000 | $68,000 | 0.01% |
| Oakworth Capital, Inc. | 3,052 | $17,000 | 0.00% |
| Spark Investment Management LLC | 10,800 | $61,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 878,348 | $5,015,000 | 0.00% |
| Renaissance Technologies | 381,471 | $2,178,000 | 0.00% |